RUA Life Sciences (FRA:AOHA) Change In Receivables : €0.12 Mil (TTM As of Sep. 2023)

View and export this data going back to . Start your Free Trial

What is RUA Life Sciences Change In Receivables?

RUA Life Sciences's change in receivables for the quarter that ended in Sep. 2023 was €0.25 Mil. It means RUA Life Sciences's Accounts Receivable declined by €0.25 Mil from Mar. 2023 to Sep. 2023 .

RUA Life Sciences's change in receivables for the fiscal year that ended in Mar. 2023 was €0.37 Mil. It means RUA Life Sciences's Accounts Receivable declined by €0.37 Mil from Mar. 2022 to Mar. 2023 .

RUA Life Sciences's Accounts Receivable for the quarter that ended in Sep. 2023 was €0.11 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. RUA Life Sciences's Days Sales Outstanding for the six months ended in Sep. 2023 was 22.59.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. RUA Life Sciences's liquidation value for the six months ended in Sep. 2023 was €-0.45 Mil.

RUA Life Sciences Change In Receivables Historical Data

The historical data trend for RUA Life Sciences's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RUA Life Sciences Change In Receivables Chart

RUA Life Sciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Receivables

Get a 7-Day Free Trial

-0.12

-0.02

-0.69

-0.06

0.37

RUA Life Sciences Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Change In Receivables	Get a 7-Day Free Trial															0.66	-0.74	0.50	-0.13	0.25

RUA Life Sciences Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.12 Mil.

RUA Life Sciences (FRA:AOHA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

RUA Life Sciences's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.114	/	0.921	*	91
=	22.59

2. In Ben Graham's calculation of liquidation value, RUA Life Sciences's accounts receivable are only considered to be worth 75% of book value:

RUA Life Sciences's liquidation value for the quarter that ended in Sep. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.572	-	1.183	+	0.75 * 0.114	+	0.5 * 0.161
=	-0.45

RUA Life Sciences Change In Receivables Related Terms

Thank you for viewing the detailed overview of RUA Life Sciences's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

RUA Life Sciences (FRA:AOHA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RUA Life Sciences PLC (FRA:AOHA) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

RUA:UK

Address

2 Drummond Crescent, Scotland, Irvine, Ayrshire, GBR, KA11 5AN

Website

https://www.rualifesciences.com

RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives its major revenue from the USA and has a presence in Europe and the Rest of the world.

RUA Life Sciences (FRA:AOHA) Headlines

No Headlines